The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 43
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte JEAN PLOUET, FREDERIC JONICA,
NATALIE ORTEGA and
MARIE-MAGDALEINE RUCHOUX
__________
Appeal No. 2004-0291
Application No. 09/091,561
__________
HEARD: May 18, 2004
__________
Before WINTERS, SCHEINER and MILLS, Administrative Patent Judges.
MILLS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. §134 from the examiner's final
rejection of claims 25-30 and 32-35. Claims 18-24 and 31, also pending in this
application, have been withdrawn from consideration.
Claim 25 is illustrative of the claims on appeal and reads as follows:
25. Anti-idiotypic vascular endothelial growth factor antibody, said antibody being
a ligand of the human KDR receptor or of the murine flk-1 and not a ligand of flt.
Page: 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007